History has shown that when manufacturers skimp on sterile filtration of drugs, the consequences can amount to the loss of hundreds of lives and millions of dollars.
Articles on Drug manufacturing
Displaying all articles
As the generics market for a particular drug gets crowded, competition on price might be driving quality issues that could harm patients.
This recall affects America’s most prescribed drug. It’s the latest in a series of concerning manufacturing issues that have come to light over the past few years.
Boosting Australia’s ability to make pharmaceuticals sounds like a great way to ease medicine shortages. But there are simpler, cheaper options we could try first.
Canadians pay very high drug costs, but Canada also does not receive the same economic benefits from pharmaceutical industry investments as other countries do.
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
The FDA receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?
Vaccine manufacturing is complex, with lots of potential points for errors. But it also has extensive quality control checks and approvals.
There are ingredients in your pills other than the one designed to treat your ailments. Those unnamed ingredients can alter how you respond to a medicine or even make you sick.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Bernard T. Ferrari Professor of Business, Johns Hopkins University
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
-
Clinical Professor, UBC Division of Endocrinology, University of British Columbia
-
Postdoctoral Fellow in Quality of Medical Products, University of California, San Francisco
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
PhD Candidate, Pharmaceutical Supply Chains, The University of Queensland
-
Director and Taylor Family Chair, Centre for the Business & Economics of Health, The University of Queensland
-
Ph.D. Candidate in Chemical Engineering, Penn State